João Lucas Pinheiro Leite
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
João Lucas Pinheiro Leite has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adriano de Souza Santos Monteiro
Laboratory of Pathology and Molecular Biology, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil
2 shared publications - Isabela Oliveira Sousa
Affiliation School of Pharmacy, Federal University of Bahia, Ondina, Salvador, Bahia, Brazil
2 shared publications - Joice Neves Reis
Faculty of Pharmacy, Federal University of Bahia, Salvador, Brazil
2 shared publications Amanda Oliveira dos Santos Melo
Affiliation School of Pharmacy, Federal University of Bahia, Ondina, Salvador, Bahia, Brazil
1 shared publication- Ana Paula Silva de Lemos
Affiliation Center of Bacteriology, National Laboratory for Meningitis and Invasive Pneumococcal Infections, Institute Adolfo Lutz, São Paulo, Brazil
1 shared publication Ana Paula de Oliveira Menezes
Affiliation State University of Bahia (UNEB), Cabula, Salvador, Bahia, Brazil
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357903
Nasopharyngeal carriage of Streptococcus pneumoniae in children aged two to five years old in the conjugate vaccine era: A cross-sectional study in Salvador, Brazil
Background: Monitoring the prevalence and serotype distribution of Streptococcus pneumoniae nasopharyngeal carriage is essential for understanding transmission dynamics and assessing the impact of pneumococcal conjugate vaccines (PCVs). In Brazil, PCV10-GSK is routinely administered at 2 and 4 months of age with a booster at 12 months. This study aimed to determine the nasopharyngeal carriage rate, serotype distribution, antimicrobial susceptibility, and factors associated with carriage among healthy children aged 2–5 years vaccinated with PCV10-GSK under the Brazilian routine immunization program. Methods: A cross-sectional study was conducted from August to November 2023 among children aged two to five years from 10 randomly selected schools in Salvador, Brazil. Within each school, all eligible children whose parents or legal guardians provided written informed consent were enrolled. Nasopharyngeal swabs were collected, and demographic, vaccination, and risk factor data were recorded. S. pneumoniae isolates were serotyped using multiplex polymerase chain reaction and/or the Quellung reaction. Antimicrobial susceptibility was evaluated using disk diffusion and gradient strip minimum inhibitory concentration methods. Risk factors for carriage were assessed using univariate and multivariable logistic regression analysis. Results: Among the 400 children enrolled, the overall S. pneumoniae carriage rate was 39.5%. White race was independently associated with lower odds of carriage compared with mixed race, whereas none of the evaluated factors was significantly associated with carriage of non-PCV20 serotypes among colonized children. The most frequent serotypes were 6C (17.9%), 19A (13.0%), 11A (9.3%), 15B (8.6%), 23A (8.6%), and 15A (7.4%). Estimated vaccine serotype carriage was 3.2% for PCV10-GSK, 17.3% for PCV13/PCV15/PCV10-SII, and 39.5% for PCV20. Penicillin non-susceptibility was observed in 21.8% of isolates, with the highest rates among serotypes 19A (71.4%), 23A (35.7%), and 6C (20.7%). Conclusions: A high pneumococcal carriage rate, predominantly involving non-PCV10-GSK serotypes, was observed among children vaccinated under the Brazilian PCV10-GSK program. The limited serotype coverage of PCV10-GSK, together with antimicrobial resistance among circulating serotypes, underscores the need for ongoing surveillance to guide vaccine policy and antimicrobial stewardship in Brazil.
- 9 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357903
Open AccessNasopharyngeal carriage of Streptococcus pneumoniae in children aged two to five years old in the conjugate vaccine era: A cross-sectional study in Salvador, Brazil
Background: Monitoring the prevalence and serotype distribution of Streptococcus pneumoniae nasopharyngeal carriage is essential for understanding transmission dynamics and assessing the impact of pneumococcal conjugate vaccines (PCVs). In Brazil, PCV10-GSK is routinely administered at 2 and 4 months of age with a booster at 12 months. This study aimed to determine the nasopharyngeal carriage rate, serotype distribution, antimicrobial susceptibility, and factors associated with carriage among healthy children aged 2–5 years vaccinated with PCV10-GSK under the Brazilian routine immunization program. Methods: A cross-sectional study was conducted from August to November 2023 among children aged two to five years from 10 randomly selected schools in Salvador, Brazil. Within each school, all eligible children whose parents or legal guardians provided written informed consent were enrolled. Nasopharyngeal swabs were collected, and demographic, vaccination, and risk factor data were recorded. S. pneumoniae isolates were serotyped using multiplex polymerase chain reaction and/or the Quellung reaction. Antimicrobial susceptibility was evaluated using disk diffusion and gradient strip minimum inhibitory concentration methods. Risk factors for carriage were assessed using univariate and multivariable logistic regression analysis. Results: Among the 400 children enrolled, the overall S. pneumoniae carriage rate was 39.5%. White race was independently associated with lower odds of carriage compared with mixed race, whereas none of the evaluated factors was significantly associated with carriage of non-PCV20 serotypes among colonized children. The most frequent serotypes were 6C (17.9%), 19A (13.0%), 11A (9.3%), 15B (8.6%), 23A (8.6%), and 15A (7.4%). Estimated vaccine serotype carriage was 3.2% for PCV10-GSK, 17.3% for PCV13/PCV15/PCV10-SII, and 39.5% for PCV20. Penicillin non-susceptibility was observed in 21.8% of isolates, with the highest rates among serotypes 19A (71.4%), 23A (35.7%), and 6C (20.7%). Conclusions: A high pneumococcal carriage rate, predominantly involving non-PCV10-GSK serotypes, was observed among children vaccinated under the Brazilian PCV10-GSK program. The limited serotype coverage of PCV10-GSK, together with antimicrobial resistance among circulating serotypes, underscores the need for ongoing surveillance to guide vaccine policy and antimicrobial stewardship in Brazil.
- Open Access
- 21 October 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (5) , e70074
High Rates of Antimicrobial Resistance and Emergence of High‐Risk Clones in Community‐Acquired Uropathogenic Escherichia coli
Urinary tract infection (UTI) is the most common bacterial infection globally and is often treated empirically in community settings, contributing to antimicrobial resistance. Uropathogenic E. coli (UPEC) is the leading cause of community‐acquired UTIs (CA‐UTIs), yet data on its clinical and molecular characteristics remain limited. To investigate the clinical and microbiological features of CA‐UTIs, focusing on antimicrobial resistance, phylogenetic groups, virulence genes, and clonal profiles. Randomly selected E. coli isolates from CA‐UTI cases underwent antimicrobial susceptibility testing. PCR was used to detect β‐lactamase genes, phylogenetic groups, and key virulence factors. MLST was used for clonal typing. Clinical and demographic data were obtained through structured interviews. Among 98 CA‐UPEC isolates, most were from female patients (95.9%), median age 48 years. High resistance was observed to ampicillin (50.0%), trimethoprim‐sulfamethoxazole (34.7%), and fluoroquinolones (33.7%), while resistance to nitrofurantoin and fosfomycin was low (1%). Multidrug resistant (MDR) strains accounted for 24.5%, with 6.1% being ESBL producers, all harboring bla CTX‐M‐type genes. Phylogenetic group B2 (48.0%) carried the most virulence genes, while group A had more MDR strains. Common virulence genes included fimH (95.9%), PAI IV 536 (77.6%), and fyuA (76.5%). Genes aer , and iutA were linked to MDR, while papC, sfa, hlyA were more common in non‐MDR isolates. ST1193, a high‐risk clone, was the most prevalent (25.0%), found only among MDR strains. ST73 and ST127 were associated with multiple virulence genes but were non‐MDR. Nitrofurantoin and fosfomycin remain effective options for CA‐UTIs. Continuous surveillance is vital to guide treatment and track resistance trends.
- 21 October 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (5) , e70074
Open AccessHigh Rates of Antimicrobial Resistance and Emergence of High‐Risk Clones in Community‐Acquired Uropathogenic Escherichia coli
Urinary tract infection (UTI) is the most common bacterial infection globally and is often treated empirically in community settings, contributing to antimicrobial resistance. Uropathogenic E. coli (UPEC) is the leading cause of community‐acquired UTIs (CA‐UTIs), yet data on its clinical and molecular characteristics remain limited. To investigate the clinical and microbiological features of CA‐UTIs, focusing on antimicrobial resistance, phylogenetic groups, virulence genes, and clonal profiles. Randomly selected E. coli isolates from CA‐UTI cases underwent antimicrobial susceptibility testing. PCR was used to detect β‐lactamase genes, phylogenetic groups, and key virulence factors. MLST was used for clonal typing. Clinical and demographic data were obtained through structured interviews. Among 98 CA‐UPEC isolates, most were from female patients (95.9%), median age 48 years. High resistance was observed to ampicillin (50.0%), trimethoprim‐sulfamethoxazole (34.7%), and fluoroquinolones (33.7%), while resistance to nitrofurantoin and fosfomycin was low (1%). Multidrug resistant (MDR) strains accounted for 24.5%, with 6.1% being ESBL producers, all harboring bla CTX‐M‐type genes. Phylogenetic group B2 (48.0%) carried the most virulence genes, while group A had more MDR strains. Common virulence genes included fimH (95.9%), PAI IV 536 (77.6%), and fyuA (76.5%). Genes aer , and iutA were linked to MDR, while papC, sfa, hlyA were more common in non‐MDR isolates. ST1193, a high‐risk clone, was the most prevalent (25.0%), found only among MDR strains. ST73 and ST127 were associated with multiple virulence genes but were non‐MDR. Nitrofurantoin and fosfomycin remain effective options for CA‐UTIs. Continuous surveillance is vital to guide treatment and track resistance trends.